Journal articleNat Commun · July 13, 2026
The most common rRNA modification is 2'-O-methylation. Here, we determine the landscape of 2'-O-methylation in Leishmania, a parasite that cycles between two different hosts, insect and mammalian. We find two 2'-O-methylated positions that are differential ...
Full textLink to itemCite
Journal articleNat Commun · May 2, 2025
Previously considered "housekeeping" genes, small nucleolar RNAs (snoRNAs) are increasingly understood to have wide-ranging functions in cancer, yet their role in metastasis has been less well studied. Here, we identify the snoRNA Snord67 as a regulator of ...
Full textLink to itemCite
Journal articleCancer Research · April 21, 2025
AbstractSmall nucleolar RNAs (snoRNAs) are a class of ncRNAs that canonically guide post-transcriptional modifications, including 2'-O-methylation, on ribosomal RNA (rRNA) and small nuclear RNA (snRNA). Whil ...
Full textCite
Journal articleNat Neurosci · December 2024
N6-methyladenosine (m6A) is an abundant mRNA modification in the brain that has important roles in neurodevelopment and brain function. However, because of technical limitations, global profiling of m6A sites within the individual cell types that make up t ...
Full textLink to itemCite
Journal articleMolecular Cancer Therapeutics · November 14, 2024
AbstractSmall nucleolar RNAs (snoRNAs) a class of ncRNAs that canonically guide post-transcriptional modifications, including 2'-O-methylation, on ribosomal RNA (rRNA) and small nuclear RNA (snRNA). While tr ...
Full textCite
Journal articleNat Biotechnol · September 2024
The N6-methyladenosine (m6A) modification is found in thousands of cellular mRNAs and is a critical regulator of gene expression and cellular physiology. m6A dysregulation contributes to several human diseases, and the m6A methyltransferase machinery has e ...
Full textLink to itemCite
Journal articleCirc Heart Fail · May 2024
BACKGROUND: Heart transplant (HT) in recipients with left ventricular assist devices (LVADs) is associated with poor early post-HT outcomes, including primary graft dysfunction (PGD). As complicated heart explants in recipients with LVADs may produce longe ...
Full textLink to itemCite
Journal articleRNA · April 16, 2024
RNA 2'-O-methylation (Nm) is highly abundant in noncoding RNAs including ribosomal RNA (rRNA), transfer RNA (tRNA), and small nuclear RNA (snRNA), and occurs in the 5' cap of virtually all messenger RNAs (mRNAs) in higher eukaryotes. More recently, Nm has ...
Full textLink to itemCite
Journal articleCirculation · November 7, 2023
Specific non-coding, small nucleolar (sno) RNAs encoded within introns of the
Rpl13a
gene elevate cellular levels of reactive oxygen species (ROS), and ROS are known to aggravate ather ...
Full textCite
Journal articleCirculation · November 7, 2023
Introduction:
Changes in substrate utilization may be a biomarker of, or a contributor to, heart failure with reduced ejection fraction (HFrEF). Previous work has described circulating metabolites, pr ...
Full textCite
Journal articleFront Oncol · 2023
While many factors have been implicated in breast cancer progression, effective treatments are still lacking. In recent years, it has become clear that posttranscriptional regulation plays a key role in the aberrant gene expression underlying malignancy an ...
Full textOpen AccessLink to itemCite
Journal articleCirculation · November 8, 2022
Reactive oxygen species (ROS) exacerbate atherosclerosis (athero). ROS levels are elevated by specific non-coding, small nucleolar (sno) RNAs encoded within introns of the
Rpl13a
gene. ...
Full textCite
Journal articleCureus · November 2022
A 52-year-old man with ischemic cardiomyopathy presented with progressive, severe orthostatic hypotension refractory to medical therapy. Standard abdominal and leg compression devices were used without success. A novel, inflatable abdominal compression dev ...
Full textOpen AccessLink to itemCite
Journal articleJ Card Fail · September 2022
Heart transplantation remains the gold-standard therapy for end-stage heart failure; the expected median survival range is 12-13 years. More than 30,000 heart transplants have been performed globally in the past decade alone. With advances in medical and s ...
Full textLink to itemCite
Journal articleCell Rep · August 30, 2022
N6-methyladenosine (m6A) is deposited co-transcriptionally on thousands of cellular mRNAs and plays important roles in mRNA processing and cellular function. m6A is particularly abundant within the brain and is critical for neurodevelopment. However, the m ...
Full textLink to itemCite
Journal articleMethods Mol Biol · 2022
Featured Publication
The ability to detect 2'-O-methylation sites (Nm) in high-throughput fashion is important, as increasing evidence points to a more diverse landscape for this RNA modification as well as the possibility of yet unidentified functions. Here we describe an opt ...
Full textLink to itemCite
Journal articleFront Cell Dev Biol · 2022
N 6-methyladenosine (m6A) is a critical regulator of gene expression and cellular function. Much of our knowledge of m6A has been enabled by the identification of m6A sites transcriptome-wide. However, global m6A profiling methods require high amounts of i ...
Full textLink to itemCite
Journal articleJ Heart Lung Transplant · December 2021
Featured Publication
PURPOSE: Clinical models to identify patients at high risk of primary graft dysfunction (PGD) after heart transplantation (HT) are limited, and the underlying pathophysiology of this common post-transplant complication remains poorly understood. We sought ...
Full textLink to itemCite
Journal articleRNA · November 2021
Pseudouridine (Ψ) is the most common noncanonical ribonucleoside present on mammalian noncoding RNAs (ncRNAs), including rRNAs, tRNAs, and snRNAs, where it contributes ∼7% of the total uridine level. However, Ψ constitutes only ∼0.1% of the uridines presen ...
Full textLink to itemCite
Journal article · 2021
Pseudouridine (Ψ) is the most common non-canonical ribonucleoside present on mammalian non-coding RNAs (ncRNAs), including rRNAs, tRNAs and snRNAs, where it contributes ∼7% of the total uridine level. However, Ψ constitutes only ∼0.1% of the uridines prese ...
Full textOpen AccessCite
Journal articleMethods Mol Biol · 2021
2'-O-methylation (Nm) is an RNA modification commonly found on rRNA and snRNA, and at the mRNA 5'-cap, but has more recently been found internally on mRNA. The study of internal Nm modifications on mRNA is in the early stages, but we have reported that thi ...
Full textLink to itemCite
Journal articleNucleic Acids Res · December 2, 2020
Featured Publication
2'-O-Methyl (Nm) is a highly abundant post-transcriptional RNA modification that plays important biological roles through mechanisms that are not entirely understood. There is evidence that Nm can alter the biological activities of RNAs by biasing the ribo ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · August 18, 2020
BACKGROUND: Monogenic diseases are individually rare but collectively common, and are likely underdiagnosed. OBJECTIVES: The purpose of this study was to estimate the prevalence of monogenic cardiovascular diseases (MCVDs) and potentially missed diagnoses ...
Full textLink to itemCite
Journal articleCirc Genom Precis Med · August 2020
Featured Publication
BACKGROUND: The discovery that much of the non-protein-coding genome is transcribed and plays a diverse functional role in fundamental cellular processes has led to an explosion in the development of tools and technologies to investigate the role of these ...
Full textLink to itemCite
Journal articleMol Cell · February 6, 2020
The RNA modification N6-methyladenosine (m6A) modulates mRNA fate and thus affects many biological processes. We analyzed m6A across the transcriptome following infection by dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), and hepatitis C vir ...
Full textLink to itemCite
Journal articleCell Host Microbe · August 14, 2019
Featured Publication
How the covalent modification of mRNA ribonucleotides, termed epitranscriptomic modifications, alters mRNA function remains unclear. One issue has been the difficulty of quantifying these modifications. Using purified HIV-1 genomic RNA, we show that this R ...
Full textLink to itemCite
Journal articleNat Commun · July 30, 2019
Featured Publication
Epitranscriptomic modifications of mRNA are important regulators of gene expression. While internal 2'-O-methylation (Nm) has been discovered on mRNA, questions remain about its origin and function in cells and organisms. Here, we show that internal Nm mod ...
Full textOpen AccessLink to itemCite
Journal articlemBio · June 11, 2019
While it has been known for several years that viral RNAs are subject to the addition of several distinct covalent modifications to individual nucleotides, collectively referred to as epitranscriptomic modifications, the effect of these editing events on v ...
Full textLink to itemCite
Journal articleJ Biol Chem · August 24, 2018
Featured Publication
Small nucleolar RNAs (snoRNAs) are noncoding RNAs that guide chemical modifications of structural RNAs. Whereas snoRNAs primarily localize in the nucleolus, where their canonical function is to target nascent ribosomal RNAs for 2'-O-methylation, recent stu ...
Full textLink to itemCite
Journal articleOncotarget · July 27, 2018
The mRNA modification N6-methyladenosine (m6A) is involved in many post-transcriptional regulatory processes including mRNA stability and translational efficiency. However, it is also imperative to correlate these processes with phenotypic outputs during c ...
Full textLink to itemCite
Journal articleRNA · September 2017
Featured Publication
Post-transcriptional regulation of mRNA during oxygen deprivation, or hypoxia, can affect the survivability of cells. Hypoxia has been shown to increase stability of a subset of ischemia-related mRNAs, including VEGF. RNA binding proteins and miRNAs have b ...
Full textLink to itemCite
Journal articleHepatology · May 2017
UNLABELLED: Diseases of the liver related to metabolic syndrome have emerged as the most common and undertreated hepatic ailments. The cause of nonalcoholic fatty liver disease is the aberrant accumulation of lipid in hepatocytes, though the mechanisms whe ...
Full textLink to itemCite
Journal articleJ Clin Invest · December 1, 2016
Featured Publication
Small nucleolar RNAs (snoRNAs) are non-coding RNAs that form ribonucleoproteins to guide covalent modifications of ribosomal and small nuclear RNAs in the nucleus. Recent studies have also uncovered additional non-canonical roles for snoRNAs. However, the ...
Full textLink to itemCite
Journal articleCell Host Microbe · November 9, 2016
Featured Publication
The RNA modification N6-methyladenosine (m6A) post-transcriptionally regulates RNA function. The cellular machinery that controls m6A includes methyltransferases and demethylases that add or remove this modification, as well as m6A-binding YTHDF proteins t ...
Full textLink to itemCite
Journal articleHeart · September 2015
OBJECTIVE: In heart failure populations without aortic stenosis (AS), the prognostic utility of multiple biomarkers in addition to clinical factors has been demonstrated. We aimed to determine whether multiple biomarkers of cardiovascular stress are associ ...
Full textLink to itemCite
Journal articleJ Biol Chem · May 1, 2015
Featured Publication
Small nucleolar RNAs (snoRNAs) guide nucleotide modifications of cellular RNAs in the nucleus. We previously showed that box C/D snoRNAs from the Rpl13a locus are unexpected mediators of physiologic oxidative stress, independent of their predicted ribosoma ...
Full textLink to itemCite
Journal articleCell Metab · July 6, 2011
Featured Publication
Lipotoxicity is a metabolic stress response implicated in the pathogenesis of diabetes complications and has been shown to involve lipid-induced oxidative stress. To elucidate the molecular mechanisms of lipotoxicity, we used retroviral promoter trap mutag ...
Full textLink to itemCite
Journal articleCardiovasc Drugs Ther · April 2011
Research into small non-coding RNAs (ncRNA) has fundamentally transformed our understanding of gene regulatory networks, especially at the post-transcriptional level. Although much is now known about the basic biology of small ncRNAs, our ability to recogn ...
Full textLink to itemCite
Journal articleJ Biol Chem · November 7, 2003
Reaper is a potent pro-apoptotic protein originally identified in a screen for Drosophila mutants defective in apoptotic induction. Multiple functions have been ascribed to this protein, including inhibition of IAPs (inhibitors of apoptosis); induction of ...
Full textLink to itemCite
Journal articleJ Biol Chem · February 7, 2003
In most cases, apoptotic cell death culminates in the activation of the caspase family of cysteine proteases, leading to the orderly dismantling and elimination of the cell. The IAPs (inhibitors of apoptosis) comprise a family of proteins that oppose caspa ...
Full textLink to itemCite
Journal articleNat Cell Biol · June 2002
Featured Publication
Inhibitors of apoptosis (IAPs) inhibit caspases, thereby preventing proteolysis of apoptotic substrates. IAPs occlude the active sites of caspases to which they are bound and can function as ubiquitin ligases. IAPs are also reported to ubiquitinate themsel ...
Full textLink to itemCite
Journal articleJ Biol Chem · February 13, 1998
Using differential display polymerase chain reaction, we cloned a novel cDNA named RoBo-1 from rat tibia. RoBo-1 is abundantly expressed in bone, including the hypertrophic chondrocytes of the growth plate where cartilage is remodeled into bone. RoBo-1 mRN ...
Full textLink to itemCite